United States Drug Enforcement Administration

WASHINGTON – A Mexican national will have his initial appearance in federal court in the District of Columbia later today on charges related to his alleged involvement in a criminal conspiracy to distribute cocaine and methamphetamine. Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division and Acting...

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

NEW YORK – DEA Special Operations Division Special Agent in Charge Wendy Woolcock and United States Attorney for the Southern District of New York Geoffrey S. Berman announced today that Juan Carlos Bonilla Valladares, aka “El Tigre,” was charged in Manhattan federal court with conspiring to import cocaine into the...

WASHINGTON – With families encouraged to stay at home due to the nationwide health crisis, the Drug Enforcement Administration is asking Americans to keep prescription medications safe and secure until they can properly dispose of them. The Secure Your Meds awareness campaign addresses a vital public safety and health issue...

WASHINGTON – The U.S. Drug Enforcement Administration has released the 2020 edition of Drugs of Abuse, A DEA Resource Guide , which is designed to be a reliable resource on the most commonly abused and misused drugs in the United States. Released on a periodic basis, Drugs of Abuse provides...

WASHINGTON – The Drug Enforcement Administration announced today that it is increasing Aggregate Production Quotas available to pharmaceutical manufacturers for the production of controlled substance medications that are in high demand due to the coronavirus (COVID-19) pandemic. DEA will also approve increases in imports of medications necessary for patients on...

WASHINGTON – The upcoming National Prescription Drug Take Back Day scheduled for Saturday, April 25, 2020 is postponed due to the ongoing coronavirus (COVID-19) pandemic. DEA will reschedule Take Back Day for a date shortly after the health crisis recedes and national emergency guidelines are lifted. The health and safety...

WASHINGTON – Former president of Venezuela Nicolás Maduro Moros, Venezuela’s vice president for the economy, Venezuela’s minister of defense, and Venezuela’s chief supreme court justice are among those charged in New York City; Washington, D.C.; and Miami, along with current and former Venezuelan government officials and two Fuerzas Armadas Revolucionarias...

WASHINGTON – During the unprecedented health emergency caused by the ongoing coronavirus (COVID-19) pandemic, the health and safety of our communities is DEA’s top priority. DEA is responding appropriately to ensure Americans continue to have access to necessary medications and controlled substances. DEA’s efforts include supporting prescribing practices that limit...

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...